Authors:
Bonfanti, P
Landonio, S
Ricci, E
Martinelli, C
Fortuna, P
Faggion, I
Quirino, T
Citation: P. Bonfanti et al., Risk factors for hepatotoxicity in patients treated with highly active antiretroviral therapy, J ACQ IMM D, 27(3), 2001, pp. 316-318
Authors:
Bonfanti, P
Valsecchi, L
Parazzini, F
Carradori, S
Pusterla, L
Fortuna, P
Timillero, L
Alessi, F
Ghiselli, G
Gabbuti, A
Di Cintio, E
Martinelli, C
Faggion, I
Landonio, S
Quirino, T
Citation: P. Bonfanti et al., Incidence of adverse reactions in HIV patients treated with protease inhibitors: A cohort study, J ACQ IMM D, 23(3), 2000, pp. 236-245
Authors:
Quirino, T
Niero, F
Ricci, E
Pusterla, L
Carradori, S
Gabbuti, A
Iemoli, E
Landonio, S
Faggion, I
Bonfanti, P
Citation: T. Quirino et al., HAART tolerability: post-exposure prophylaxis in healthcare workers versustreatment in HIV-infected patients, ANTIVIR TH, 5(3), 2000, pp. 195-197
Authors:
Bonfanti, P
Pusterla, L
Parazzini, F
Libanore, M
Cagni, AE
Franzetti, M
Faggion, I
Landonio, S
Quirino, T
Citation: P. Bonfanti et al., The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study, BIOMED PHAR, 54(1), 2000, pp. 45-49
Authors:
Franzetti, F
Gori, A
Iemoli, E
Meraviglia, P
Mainini, F
Quirino, T
degli Esposti, A
degl'Innocenti, M
Grassini, A
Nardi, G
Cargnel, A
Citation: F. Franzetti et al., Outcome of multidrug-resistant tuberculosis in human immunodeficiency virus-infected patients, CLIN INF D, 29(3), 1999, pp. 553-560
Authors:
Quirino, T
Bonfanti, P
Arcidiacono, M
Pusterla, L
Cagni, A
Scaglione, F
Milazzo, F
Citation: T. Quirino et al., Acetylator phenotype prevalence in HIV-infected patients without previous trimethoprim-sulfamethoxazole hypersensitivity, BIOMED PHAR, 53(5-6), 1999, pp. 286-287